[Tropmed-l] Chromoblastomycosis 100 years

[Antônio Bandeira]

Not that I am aware of.
However we had a few cases where Ambisome had been used.
Best regards,

*Dr. Antônio Bandeira*
*Hospital Couto Maia, Hospital Aliança*
*Faculdade de Tecnologia e Ciências, Salvador, Brazil*


On Sun, Dec 7, 2014 at 11:58 AM, Flavio Queiroz Telles <
queiroz.telles em uol.com.br> wrote:

>
> Dear All
>
> I am looking for some evidence about the use of the lipid formulations oaf
> Ampho B (ABELCET and AMBISOME) for the therapy of refractory or intolerant
> mucocutaneous leishmaniasis?
> Is there any published controlled clinical trial?
> Bets Regards
> Flavio Queiroz-Telles
> Federal University of Parana, Brazil
>
>
> --
> * This email was sent by icb.usp.br <http://icb.usp.br> *   ­­
>
> _______________________________________________
> TropMed-L mailing list
> TropMed-L em lineu.icb.usp.br
> http://lineu.icb.usp.br/cgi-bin/mailman/listinfo/tropmed-l
>
> --
> This email was sent by icb.usp.br
>
>
-------------- Pr�xima Parte ----------
Um anexo em HTML foi limpo...
URL: <http://lineu.icb.usp.br/pipermail/tropmed-l/attachments/20150422/a19450ce/attachment-0001.htm>